Barclays PLC Rigel Pharmaceuticals Inc Call Options Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $36,816 - $55,692	15,600 Added 780.0%	17,600 $47,000
Q1 2018 May 15, 2018	SELL	$3.54 - $4.54 $70,800 - $90,800	-20,000 Reduced 90.91%	2,000 $7,000
Q4 2017 Feb 14, 2018	SELL	$3.23 - $4.3 $646 - $860	-200 Reduced 0.9%	22,000 $85,000
Q3 2017 Nov 14, 2017	BUY	$2.18 - $2.57 $48,396 - $57,054	22,200	22,200 $57,000

355K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.24B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.